Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
letter
. 2003 May;95(5):404–405.

Ethnic differences in incidence of diseases and response to medicines.

Tsung O Cheng
PMCID: PMC2594510  PMID: 12793799

Full text

PDF
404

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cheng T. O. Importance of ethnic differences in affecting the outcomes of international trials. Eur Heart J. 2002 Feb;23(3):256–256. doi: 10.1053/euhj.2001.3057. [DOI] [PubMed] [Google Scholar]
  2. Cheng T. O. Maintenance doses of warfarin in Chinese patients. QJM. 1996 Jul;89(7):557–557. doi: 10.1093/qjmed/89.7.557. [DOI] [PubMed] [Google Scholar]
  3. Cheng Tsung O. Ethnic differences in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Int J Cardiol. 2002 Jun;83(3):293–291. doi: 10.1016/s0167-5273(02)00068-2. [DOI] [PubMed] [Google Scholar]
  4. Gifford Allen L., Cunningham William E., Heslin Kevin C., Andersen Ron M., Nakazono Terry, Lieu Dale K., Shapiro Martin F., Bozzette Samuel A., HIV Cost and Services Utilization Study Consortium Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med. 2002 May 2;346(18):1373–1382. doi: 10.1056/NEJMsa011565. [DOI] [PubMed] [Google Scholar]
  5. King Talmadge E., Jr Racial disparities in clinical trials. N Engl J Med. 2002 May 2;346(18):1400–1402. doi: 10.1056/NEJM200205023461812. [DOI] [PubMed] [Google Scholar]
  6. Liu Simin, Buring Julie E., Sesso Howard D., Rimm Eric B., Willett Walter C., Manson JoAnn E. A prospective study of dietary fiber intake and risk of cardiovascular disease among women. J Am Coll Cardiol. 2002 Jan 2;39(1):49–56. doi: 10.1016/s0735-1097(01)01695-3. [DOI] [PubMed] [Google Scholar]
  7. Ross A. M., Gao R., Coyne K. S., Chen J., Yao K., Yang Y., Qin X., Qiao S., Yao M., TUCC Investigators A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial. Am Heart J. 2001 Aug;142(2):244–247. doi: 10.1067/mhj.2001.116963. [DOI] [PubMed] [Google Scholar]
  8. Van de Werf F. Why is there so much geographic variation in clinical outcome in international trials of fibrinolytic therapy? Eur Heart J. 2001 Sep;22(18):1631–1632. doi: 10.1053/euhj.2001.2700. [DOI] [PubMed] [Google Scholar]
  9. Woo K. S., Norris R. M., Nicholls G. Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol. 1995 May 1;75(14):967–968. doi: 10.1016/s0002-9149(99)80703-6. [DOI] [PubMed] [Google Scholar]
  10. Yip G. W., Ho P. P., Woo K. S., Sanderson J. E. Comparison of frequencies of left ventricular systolic and diastolic heart failure in Chinese living in Hong Kong. Am J Cardiol. 1999 Sep 1;84(5):563–567. doi: 10.1016/s0002-9149(99)00378-1. [DOI] [PubMed] [Google Scholar]
  11. Yu H. C., Chan T. Y., Critchley J. A., Woo K. S. Factors determining the maintenance dose of warfarin in Chinese patients. QJM. 1996 Feb;89(2):127–135. doi: 10.1093/qjmed/89.2.127. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES